niacinamide has been researched along with exenatide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Ferber, S; Linning, KD; Madhukar, BV; Olson, LK; Reed, DN; Tai, MH; Trosko, JE | 1 |
| Afşar, S; Akkan, AG; Kutluata, N; Ozdaş, SB; Ozyazgan, S | 1 |
| Anker-Kitai, L; Efrat, S; Zalzman, M | 1 |
| Gupta, S | 1 |
| Emami, SH; Moshtagh, PR; Sharifi, AM | 1 |
| Chen, T; Kagan, L; Mager, DE | 1 |
| Campani, D; Canistro, D; De Siena, R; De Tata, V; Funel, N; Martano, M; Masiello, P; Masini, M; Melega, S; Novelli, M; Paolini, M; Pippa, A; Sapone, A; Soleti, A; Vecoli, C | 1 |
| Jiang, X; Li, Y; Su, X; Sun, M; Tan, Y; Wang, Y; Wintergerst, KA; Xin, Y; Zhang, L | 1 |
| El-Kholy, Ael-L; El-Mesallamy, HO; Kamal, MM; Kassem, DH | 1 |
| Gao, D; Jin, L; Ku, HT; Luo, A; Quijano, J; Rawson, J; Tremblay, JR; Wedeken, L | 1 |
| Cine, N; Ertan, M; Gumuslu, E; Komsuoglu Celikyurt, I; Mutlu, O; Ulak, G | 1 |
1 review(s) available for niacinamide and exenatide
| Article | Year |
|---|---|
Immunotherapies in diabetes mellitus type 1.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Azathioprine; Basiliximab; Chaperonin 60; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Diet; Etanercept; Exenatide; Fatty Acids, Unsaturated; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Insulin; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Islets of Langerhans Transplantation; Niacinamide; Peptide Fragments; Peptides; Primary Prevention; Pyrazines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Secondary Prevention; Sitagliptin Phosphate; Tertiary Prevention; Triazoles; Venoms; Vitamin D; Vitamins | 2012 |
10 other study(ies) available for niacinamide and exenatide
| Article | Year |
|---|---|
Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
Topics: Acetylcysteine; Adenoviridae; Adult; Albumins; alpha-Amylases; C-Peptide; Cell Aggregation; Cell Differentiation; Cell Separation; Cells, Cultured; Chromones; Culture Media; Culture Media, Serum-Free; Exenatide; Gene Expression Regulation; Genetic Vectors; Glucagon; Homeodomain Proteins; Humans; Insulin; Intermediate Filament Proteins; Intracellular Fluid; Islets of Langerhans; Morpholines; Nerve Tissue Proteins; Nestin; Niacinamide; Oxidation-Reduction; Peptides; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Stem Cells; Trans-Activators; Transcription Factors; Venoms; Vimentin | 2004 |
Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Topics: Animals; Aorta, Thoracic; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Oxidative Stress; Peptide Fragments; Peptides; Rats; Rats, Wistar; Streptozocin; Vasodilator Agents; Venoms | 2005 |
Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype.
Topics: Activins; Betacellulin; Cell Differentiation; Exenatide; Gene Expression Regulation; Hepatocytes; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Inhibin-beta Subunits; Insulin; Intercellular Signaling Peptides and Proteins; Niacinamide; Nuclear Proteins; Peptides; Phenotype; Stem Cells; Trans-Activators; Transcription Factors; Venoms | 2005 |
Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study.
Topics: Adipose Tissue; Adult; Biomarkers; Cell Differentiation; Cells, Cultured; Culture Media; Exenatide; Glucose; Humans; Insulin; Insulin-Secreting Cells; Mercaptoethanol; Mesenchymal Stem Cells; Microscopy, Phase-Contrast; Niacinamide; Peptides; Venoms | 2013 |
Population pharmacodynamic modeling of exenatide after 2-week treatment in STZ/NA diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Exenatide; Glucose Tolerance Test; Hypoglycemic Agents; Injections, Subcutaneous; Male; Niacinamide; Peptides; Rats; Rats, Sprague-Dawley; Streptozocin; Venoms | 2013 |
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Exenatide; Free Radical Scavengers; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Niacinamide; Oxidative Stress; Peptides; Pioglitazone; Random Allocation; Streptozocin; Thiazolidinediones; Venoms | 2014 |
Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Topics: Adipocytes; Animals; Apoptosis; Bone Marrow Cells; Calcium Channels; Cell Differentiation; Chondrocytes; Culture Media; Diabetes Mellitus, Experimental; Dithizone; Exenatide; Glucose; Humans; Hyperglycemia; Insulin; Insulin-Secreting Cells; Karyotyping; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Osteogenesis; Peptides; Phenotype; Streptozocin; Transplantation, Heterologous; Venoms | 2016 |
Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers.
Topics: Biomarkers; Cell Differentiation; Cells, Cultured; Exenatide; Glucose; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Insulin; Insulin-Secreting Cells; Mercaptoethanol; Mesenchymal Stem Cells; Niacinamide; Nuclear Proteins; Peptides; Stem Cells; Transcription Factors; Venoms; Wharton Jelly | 2016 |
Adult Murine Pancreatic Progenitors Require Epidermal Growth Factor and Nicotinamide for Self-Renewal and Differentiation in a Serum- and Conditioned Medium-Free Culture.
Topics: Acinar Cells; Activins; Adult Stem Cells; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Epidermal Growth Factor; Exenatide; Extracellular Matrix Proteins; Female; Insulin-Secreting Cells; Male; Mice; Niacinamide; Pancreas; Peptides; Receptors, Notch; Vascular Endothelial Growth Factor A; Venoms | 2017 |
Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide-1 Receptor; Hippocampus; Hypoglycemic Agents; Incretins; Male; Mice, Inbred BALB C; Nerve Growth Factor; Niacinamide; Peptides; Streptozocin; Time Factors; Up-Regulation; Venoms | 2018 |